Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Lisata Therapeutics (LSTA) over the last 6 years, with Q3 2025 value amounting to $2000.0.

  • Lisata Therapeutics' Exchange Rate Effect fell 9487.18% to $2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$56000.0, marking a year-over-year increase of 1515.15%. This contributed to the annual value of -$55000.0 for FY2024, which is 24375.0% down from last year.
  • Latest data reveals that Lisata Therapeutics reported Exchange Rate Effect of $2000.0 as of Q3 2025, which was down 9487.18% from $5000.0 recorded in Q2 2025.
  • In the past 5 years, Lisata Therapeutics' Exchange Rate Effect registered a high of $75000.0 during Q3 2023, and its lowest value of -$76000.0 during Q4 2023.
  • Its 3-year average for Exchange Rate Effect is -$5636.4, with a median of $2000.0 in 2025.
  • Within the past 5 years, the most significant YoY rise in Lisata Therapeutics' Exchange Rate Effect was 42500.0% (2024), while the steepest drop was 68571.43% (2024).
  • Over the past 3 years, Lisata Therapeutics' Exchange Rate Effect (Quarter) stood at -$76000.0 in 2023, then grew by 14.47% to -$65000.0 in 2024, then skyrocketed by 103.08% to $2000.0 in 2025.
  • Its last three reported values are $2000.0 in Q3 2025, $5000.0 for Q2 2025, and $2000.0 during Q1 2025.